Social Capital Suvretta Holdings Corp. III

announced
PROKSEC EDGARCIK: 0001850270|SCS Sponsor III LLC•Biotechnology

Capital Structure & Economics

Trust Size$200,000,000
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

No Warrants / No Drag
Public Trust Allocation$200,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedJun 2, 2021
Target AnnouncedJan 18, 2022
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyPKLP
  • SectorBiotechnology
  • Announcement Date2022-01-18

Board & Officers

  • Bruce CulletonCEO
  • Chamath Palihapitiya(8)
    Officer
  • Kishen Mehta(2)
    Officer
  • Pablo LegorretaDirector
  • William F. DoyleDirector
  • Alan M. Lotvin, M.D.Director
  • Brian J. G. Pereira, M.D.Director
  • Uma Sinha, Ph.D.Director
  • John M. Maraganore, Ph.D.Director
  • José Ignacio Jiménez SantosDirector
  • Jennifer Fox(2)
    Director
  • James Ryans, Ph.D.Director
  • Marc Semigran, M.D.Director
  • Marc SemigranDirector

Advanced Structuring Terms

Target SectorsBiotechnology

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction